Abstract:The present study identified several problems and highlighted areas for improvement in the management and documentation for intravascular devices. Ongoing education, promoting good clinical practice and reauditing, can be applied to improve the management of devices.
“…In a study undertaken in Australia, involving 327 patients, 190 (86.4%) of whom received peripheral venous catheterization, lack of daily care records on the venipunctures and their use was found, highlighting the importance of training the professionals and promoting the best clinical practices. (5) These research results are applicable as they can help the professionals to choose the best or most appropriate peripheral venous catheter technology for the therapeutics prescribed to the patient in the care process. The findings can permeate public policies, clinical guidelines, protocols and standard procedures in patient care with a view to reduce the occurrence of complications.…”
Section: Discussionmentioning
confidence: 99%
“…(3) In Spain, about 50% of the inpatients receive an intravenous catheter, 95% of which are peripheral. (4) Other studies appoint usage rates of peripheral venous catheters in 86.4% (5) and 80.6% (6) of the patients. Thus, the nurses and nursing team's technical-scientific knowledge about intravenous therapy guarantee the treatment efficacy and the quality of care delivery, making it fundamental to know the best technologically and evidence-based care practices.…”
Objective: To analyze the complications deriving from the use and type of peripheral venous catheter in adults. Methods: Randomized clinical trial; undertaken at a teaching hospital between 2012 and 2015; 169 adults were included who were hospitalized at clinical and surgical services and needed peripheral venipuncture with an expected dwelling time of more than 96 hours. Through systemized randomization, 90 participants were allocated to the trial group (complete safety catheter) and 79 to the control group (short flexible catheter). Results: The general complications rate was 55.62%, with 18.34% of phlebitis, 11.83% infiltration, 11.24% obstruction and 9.47% traction. No significant difference was found between the groups for the occurrence of complications, phlebitis, obstruction and traction. Conclusion: The complication rate in peripheral venous catheterization was high but, when compared, without a statistically significant difference, the complete safety catheter showed lower complication rates after the fourth day of survival.
ResumoObjetivo: Analisar as complicações decorrentes do uso e tipo de cateter venoso periférico em adultos. Métodos: Ensaio clínico randomizado; realizado em um hospital de ensino, no período de 2012 a 2015; incluiu-se 169 adultos internados em unidades clínicas e cirúrgicas que necessitaram de punção venosa periférica e com permanência prevista de mais de 96 horas. A randomização aleatória sistematizada alocou 90 participantes no Grupo Experimental (cateter de segurança completo) e 79 no Grupo Controle (cateter curto flexível). Resultados: A taxa geral de complicações foi 55,62%, houve 18,34% de flebite, infiltração 11,83%, obstrução 11,24% e tração 9,47%. Não houve diferença significativa entre os grupos para a ocorrência de complicações, flebite, obstrução e tração. Conclusão: A taxa de complicações no cateterismo venoso periférico foi alta, mas quando comparados, sem diferença estatística significativa, o cateter de segurança completo teve taxas menores de complicações após o quarto dia de sobrevida.Brazilian Clinical Trial Registers (ReBEC): RBR-46ZQR8
“…In a study undertaken in Australia, involving 327 patients, 190 (86.4%) of whom received peripheral venous catheterization, lack of daily care records on the venipunctures and their use was found, highlighting the importance of training the professionals and promoting the best clinical practices. (5) These research results are applicable as they can help the professionals to choose the best or most appropriate peripheral venous catheter technology for the therapeutics prescribed to the patient in the care process. The findings can permeate public policies, clinical guidelines, protocols and standard procedures in patient care with a view to reduce the occurrence of complications.…”
Section: Discussionmentioning
confidence: 99%
“…(3) In Spain, about 50% of the inpatients receive an intravenous catheter, 95% of which are peripheral. (4) Other studies appoint usage rates of peripheral venous catheters in 86.4% (5) and 80.6% (6) of the patients. Thus, the nurses and nursing team's technical-scientific knowledge about intravenous therapy guarantee the treatment efficacy and the quality of care delivery, making it fundamental to know the best technologically and evidence-based care practices.…”
Objective: To analyze the complications deriving from the use and type of peripheral venous catheter in adults. Methods: Randomized clinical trial; undertaken at a teaching hospital between 2012 and 2015; 169 adults were included who were hospitalized at clinical and surgical services and needed peripheral venipuncture with an expected dwelling time of more than 96 hours. Through systemized randomization, 90 participants were allocated to the trial group (complete safety catheter) and 79 to the control group (short flexible catheter). Results: The general complications rate was 55.62%, with 18.34% of phlebitis, 11.83% infiltration, 11.24% obstruction and 9.47% traction. No significant difference was found between the groups for the occurrence of complications, phlebitis, obstruction and traction. Conclusion: The complication rate in peripheral venous catheterization was high but, when compared, without a statistically significant difference, the complete safety catheter showed lower complication rates after the fourth day of survival.
ResumoObjetivo: Analisar as complicações decorrentes do uso e tipo de cateter venoso periférico em adultos. Métodos: Ensaio clínico randomizado; realizado em um hospital de ensino, no período de 2012 a 2015; incluiu-se 169 adultos internados em unidades clínicas e cirúrgicas que necessitaram de punção venosa periférica e com permanência prevista de mais de 96 horas. A randomização aleatória sistematizada alocou 90 participantes no Grupo Experimental (cateter de segurança completo) e 79 no Grupo Controle (cateter curto flexível). Resultados: A taxa geral de complicações foi 55,62%, houve 18,34% de flebite, infiltração 11,83%, obstrução 11,24% e tração 9,47%. Não houve diferença significativa entre os grupos para a ocorrência de complicações, flebite, obstrução e tração. Conclusão: A taxa de complicações no cateterismo venoso periférico foi alta, mas quando comparados, sem diferença estatística significativa, o cateter de segurança completo teve taxas menores de complicações após o quarto dia de sobrevida.Brazilian Clinical Trial Registers (ReBEC): RBR-46ZQR8
“…A further concern is that most PIVC assessment tools do not assess the continued need for or function of the cannula, dressing and securement integrity, adherence to infection prevention standards, patient preference and education needs. With PIVC failure rates ranging from 30-50% (Marsh et al, 2017;New, Webster, Marsh, & Hewer, 2014;Wallis et al, 2014), assessment should include more than simply identifying phlebitis and/or infiltration. Comprehensive tools to improve patient outcomes need to be developed and validated (Alexander, 2017;Rickard & Ray-Barruel, 2017).…”
Improving the safety and quality of health care relies on implementing evidence-based findings into every-day clinical practice. Numerous clinical decision aids have been developed to guide nursing care of the patient with a peripheral intravenous catheter (PIVC), including standards, guidelines, decision frameworks, bundles, policies, procedures, algorithms, pathways, checklists and scoring tools. While all are created with the intention of facilitating the delivery of safe, effective nursing care and improving patient outcomes, there are distinct differences in methodology and design between them, and many are based on expert opinion and historical practice rather than high-quality evidence. This paper reviews the types of decision aids for daily PIVC assessment and management, explores the evidence base underpinning them, and considers the implications for their use in clinical practice. A consistent, systematic and evidence-based approach to PIVC care will provide the optimal environment for achieving quality patient outcomes.
“…More than 70% of patients admitted to hospitals require peripheral intravenous
catheters
2
. Other studies show the use of peripheral venous catheters in 86.4%
4
and 80.6%
5
of the patients.…”
Objective:analyze the risk factors linked to complications in peripheral intravenous
catheters. Method:secondary data analysis of a randomized controlled trial with 169 medical and
surgical patients placed in two groups, one with integrated safety catheter (n=90)
and other using simple needle catheter (n=79), with three months follow-up time.
Results:the risk factors that raised the odds of developing complications were:
hospitalization between 10-19 days (p=0.0483) and 20-29 days (p=0,0098),
antimicrobial use (p=0.0288) and use of fluid solutions (p=0.0362). The 20 Gauge
lowered the risks of complications (p=0.0153). Multiple analysis showed reduction
of risk for the 20 Gauge (p=0.0350); heightened risk for solutions and fluids
(p=0.0351) and use of corticosteroids (p=0.0214). Conclusion:risk factors linked to complications in peripheral intravenous catheters were:
hospitalization periods between 10-29 days, antimicrobial infusion, solutions and
fluids and corticosteroids. Regarding complications, 20 Gauge is a protecting
factor compared with 22. Brazilian Clinical Trials Registry: RBR-46ZQR8.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.